Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × ridaforolimus × Clear all

NCT00110188 2015-11-20

Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017)

Phase 2 Completed

Neoplasms, Prostatic Neoplasms

NCT00777959 2015-08-19

Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002)

Phase 2 Completed

Prostatic Neoplasms